SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Orchid Pharma

BSE: 524372|NSE: ORCHIDPHAR|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 19, 16:00
28.65
0.1 (0.35%)
VOLUME 56,141
LIVE
NSE
Jan 19, 15:48
28.60
0.05 (0.18%)
VOLUME 162,370
Announcements on Orchid Pharma

19th-Jan-2017 17:45Source: BSE

Orchid Pharma- Shareholding for the Period Ended December 31, 2016

Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly

13th-Jan-2017 11:35Source: BSE

Orchid Pharma- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016

Orchid Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listin...

28th-Dec-2016 14:41Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Raghavendra Rao & R Vijayalakshmi

19th-Dec-2016 17:43Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Raghavendra Rao

9th-Nov-2016 15:48Source: BSE

Orchid Pharma- Standalone Financial Results, Limited Review Report, Results Press Release for September 30, 2016

Orchid Pharma Ltd has informed BSE about :

1. Standalone Financial Results for the period ended September 30, 2016

2. Standalone Limited Review for the period ended September 30, 2016

1st-Nov-2016 17:09Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

27th-Oct-2016 18:17Source: BSE

Orchid Pharma- Board Meeting Intimation for Results & Closure of Trading Window

Orchid Pharma Ltd has informed BSE that a meeting of the Board of Directors is proposed to be held on November 09, 2016, to approve the unaudited financial results of the Company for the period from J...

21st-Oct-2016 15:24Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghvendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

21st-Oct-2016 12:42Source: BSE

Orchid Pharma- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016

Orchid Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listi...

21st-Oct-2016 11:40Source: BSE

Orchid Pharma- Shareholding for the Period Ended September 30, 2016

Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly

Quick Links for Orchid Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.